Jeil Pharma Holdings Inc

Informe acción KOSE:A002620

Capitalización de mercado: ₩168.9b

Jeil Pharma Holdings Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Seung-Soo Han

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO66.0%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

Mar 25
Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

Feb 27
These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jan 23
What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Dec 28
Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

Nov 23
Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

CEO

Seung-Soo Han (76 yo)

no data

Permanencia

Seung Soo Han serves the Chairman of the Board and Chief Executive Officer of Jeil Pharma Holdings Inc (formerly known as Jeil Pharmaceutical Co., Ltd.)